Tag: Hatch-Waxman Act
Generic drugs saved the U.S. healthcare system $3.4 trillion from 2015-2024. Learn how Hatch-Waxman, biosimilars, and market competition drive these massive savings and what challenges remain.
Explore how the FDA approves generic drugs via the ANDA process, ensuring safety and savings. Learn about bioequivalence standards, GDUFA timelines, and the impact of the Hatch-Waxman Act on your medication.
Medications
Archives
Recent-posts
Insulin Allergies: How to Spot and Handle Injection Reactions
Jan, 11 2026
The Future of Bladder Infection Treatments: New Research and Innovations
Sep, 24 2025
How to Confirm Your Name and Medication on a Prescription Label Safely
Apr, 1 2026
Peppermint Oil for IBS: What the Science Says and How to Use It Right
Dec, 6 2025
Kidney Function Tests: Creatinine, GFR, and Urinalysis Explained
Nov, 19 2025